Abstract
Proteomics, as is by now very well known, is a term used to describe a
multitude of processes employed in deciphering the form, function and
inter-actions of molecular proteins. Proteomics has evolved as a natural
progression from genomics over the past 20 years or so, and plays a vital role
in the discovery of new drugs. Most diseases are caused by faulty or absent
proteins. Researchers in proteomics currently depend on two key technologies 2-D
electrophoresis to separate the proteins for analysis and mass spectrometry for
their identification and characterisation. In addition to the major application
of protein identification, mass spectrometry is also used within the life
sciences for peptide sequencing, identification of post-translational
modification, characterisation of multi protein complexes as well as use in
small molecule and ADME Tox applications. This report investigates the market
for MS commercial instruments in the European Life Science Market.
View Cart
